🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07654504
Recruiting Observational

Validity and Reliability of the Turkish Version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)

NCT07654504 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08-01
Last updated
2026-06-17

Condition(s) studied

Brachial Plexus Birth PalsyBrachial Plexus PalsyBrachial Plexus Palsy Due to Birth TraumaObstetric Brachial Plexus Injury

Investigational drug(s) / intervention(s)

Questionnaire Assessment Battery

Questionnaire Assessment Battery: Participants will complete the Turkish version of the Impact of Brachial Plexus Injury Questionnaire, the Disabilities of the Arm, Shoulder and Hand questionnaire, and the Short Form-36.

Study summary

The aim of this methodological study is to translate the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ) into Turkish, culturally adapt it, and evaluate its validity and reliability for use in adults with brachial plexus birth palsy. The study will include 50 adult participants aged 18 years and older with a diagnosis of brachial plexus birth palsy. Participants will complete the Turkish version of the IMBPIQ, as well as the Disabilities of the Arm, Shoulder and Hand questionnaire and the Short Form-36. The psychometric properties of the Turkish IMBPIQ will be examined using reliability and validity analyses, including internal consistency, test-retest reliability, and construct validity.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being 18 years of age or older. * Having a diagnosis of brachial plexus birth palsy. * Having the ability to read, write, speak, and understand Turkish. * Agreeing to participate voluntarily in the study and signing the informed consent form. Exclusion Criteria: * Having a neurological disease. * Having another orthopedic problem or a history of trauma in the affected upper extremity. * Having a severe cognitive or communication impairment that may prevent completion of the questionnaires or understanding of the study instructions. * Having a history of systemic disease requiring an acute attack or hospitalization within the last three months. * Being pregnant or being in the postpartum period of less than 6 months.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Biruni University Istanbul Istanbul Recruiting

More Biruni University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07654504 on ClinicalTrials.gov ↗ ← All trials in Turkey